Assessment of the catalytic and biological potential of yttrium and samarium-modified copper ferrite nanomaterials.

The present study reports the preparation of crystalline and nanosized copper ferrite (CuFe2O4), Y3+ substituted CuFe2O4 (CuFe1.95Y0.05O4), and Sm3+ substituted CuFe2O4 (CuFe1.95Sm0.05O4) using a simple co-precipitation method. The XRD analysis confirmed the formation of the cubic spinel phase, while XPS studies validated the presence of Cu and Fe in 2+ and 3+ oxidation states respectively. Transmission electron microscopy (TEM) analysis revealed the nanoparticles with a diameter in the range of 10-60 nm. The introduction of fractional amounts of Y3+ and Sm3+ ions in the CuFe2O4 lattice enhanced the reduction of 4-nitrophenol, attributed to decreased particle size facilitating the reduction process. In the case of antimicrobial activity, Candida albican was found to be maximally sensitive to CuFe2O4 and CuFe1.95Y0.05O4, while Pseudomonas aeruginosa was inhibited by CuFe1.95Sm0.05O4. Moreover, a maximum of 61.9 ± 1.91 % anti-Pseudomonas biofilm activity and 75.7 ± 1.28 % DPPH radical scavenging activity was observed for CuFe1.95Y0.05O4 at 200 µg/ml concentration. The improvement in biological activities was attributed to the reduced particle size, crystal structure modification, and increased stability of the CuFe2O4 lattice with substitution. The enhancement in catalytic and biological performance highlighted the effectiveness of minimal Y3+ and Sm3+ concentrations in modulating the properties of CuFe2O4 nanomaterials.

Characterization of Mn3 O4 -MnO2 nanocomposites biosynthesized by cell lysate of Haloferax alexandrinus GUSF-1.

Manganese oxide nanocomposites attract huge attention in various biotechnological fields due to their extensive catalytic properties. This study reports an easy, rapid, and cost-effective method of using the cell lysate of haloarchaeon, Haloferax alexandrinus GUSF-1 for the synthesis of manganese oxide nanoparticles. The reaction between the cell lysate and manganese sulfate resulted in the formation of a dark brown precipitate within 48 h at room temperature. The X-ray diffraction pattern showed the existence of Mn3 O4 and MnO2 phases consistent with the JCPDS card no. (01-075-1560 and 00-050-0866). The dark brown colloidal suspension of MnO3 -MnO2 in methanol showed maximum absorption between 220 and 260 nm. The EDX spectrum confirmed the presence of manganese and oxygen. The Transmission electron microscopy revealed the spherical morphology with an average particle size between 30 and 60 nm. The magnetic moment versus magnetic field (MH) curve, at room temperature (300 K) did not saturate even at a high magnetic field (±3T) indicating the paramagnetic nature of the prepared nanocomposite. The Atomic Emission Spectroscopic analysis showed a negligible amount of soluble manganese (0.03 ppm in 50 ppm) in the Mn3 O4 -MnO2 suspension suggesting the maximum stability of the material in the solvent over time. Interstingly, Mn3 O4 -MnO2 nanocomposites evidenced antimicrobial activity in the order of Pseudomonas aeruginosa > Salmonella typhi > Escherichia coli > Proteus vulgaris > Candida albicans > Staphylococcus aureus. Conclusively, this is the first report on the formation of Mn3 O4 -MnO2 nanocomposites using cell lysate of salt pan haloarcheon Haloferax alexandrinus GUSF-1 with antimicrobial potential.